David Ricks, Eli Lilly CEO (Paulo Nunes dos Santos/Bloomberg via Getty Images)

Lil­ly puts $27B in­to new US drug man­u­fac­tur­ing, cred­it­ing Trump push

Eli Lil­ly is con­tin­u­ing to in­vest big in US phar­ma man­u­fac­tur­ing, with the ad­di­tion of three new do­mes­tic API sites and an­oth­er in­jecta­bles site, cre­at­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.